Avenu Medical is a private medical technology company focused on creating a minimally invasive arteriovenous fistulae for patients on dialysis due to end-stage renal disease, the release said. AV fistulae connect a vein and artery in the arm for dialysis; however, it’s normally created in an open surgery.
Avenu Medical’s Ellipsys Vascular Access System uses a single-catheter, ultrasound-guided device to create a sturdy AV fistula, the release said. The procedure can be done in an outpatient setting.
“Medtronic’s acquisition of Avenu aligns directly with our vision of bringing less invasive, endovascular solutions to patients requiring durable vascular access,” Mark Ritchart, president and CEO of Avenu Medical, said in the statement. “With Medtronic’s extensive market presence, clinical leadership, and market development expertise, coupled with Avenu’s customer-focused team and innovative technology, we are confident that together, we can drive awareness and adoption of this technology globally.”
Terms of the acquisition weren’t immediately available, the statement said. The deal is planned to close in October.
Read the full press release here.
More articles on surgery centers:
Surgalign Holdings to acquire Holo Surgical, digital surgery platform valued up to $125M
California surgery center receives medical supplies from Armenia
Smith+Nephew introduces remote OR access through partnership — 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
